Long-term safety of mepolizumab for up to ∼10 years in patients with severe asthma: open-label extension study
Jorge Fernando Maspero, Nicola Brown, Robert Chan, Robert G. Price et al.
Citations
19 citations
Journal
Annals of Medicine
Topics
Asthma and respiratory diseases
Field-Weighted Citation Impact (FWCI)
6.20
article
Long-term safety of mepolizumab for up to ∼10 years in patients with severe asthma: open-label extension study
Jorge Fernando Maspero, Nicola Brown, Robert Chan, Robert G. Price, Ian Pavord, Peter Howarth, M Gilson
article en
19 citations
Abstract
No abstract available for this paper.
Publication Tag
Annals of MedicineVol. 56(1)
Institutions
National Institute for Health and Care Research (GB), University of Oxford (GB), Fundación para la Investigación, Docencia y Prevención del Cáncer (AR)